Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Guidant

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 10
Average round size
info
The average size of a deal this fund participated in
$13M
Portfolio companies 8
Rounds per year 0.37
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.20
Exits 5
Key employees Soon

Areas of investment

  • Health Care
  • Medical Device
  • Biotechnology
  • Medical
  • Pharmaceutical
Summary

Guidant is the famous Corporate Investor, which was founded in 1994. The main office of represented Corporate Investor is situated in the Indianapolis. The venture was found in North America in United States.

The important activity for fund was in 2004. Deals in the range of 10 - 50 millions dollars are the general things for fund. The typical startup value when the investment from Guidant is 100-500 millions dollars. Speaking about the real fund results, this Corporate Investor is 5 percentage points more often commits exit comparing to other organizations. The fund is generally included in less than 2 deals every year. This Guidant works on 21 percentage points more the average amount of lead investments comparing to the other organizations. The higher amount of exits for fund were in 2008.

The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Guidant, startups are often financed by Sanderling Ventures, Biofrontier Partners, Versant Ventures. The meaningful sponsors for the fund in investment in the same round are Three Arch Partners, Sanderling Ventures, Oxford Bioscience Partners. In the next rounds fund is usually obtained by New Enterprise Associates, Versant Ventures, Three Arch Partners.

For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. Among the most successful fund investment fields, there are Medical Device, Therapeutics. The fund has no specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Intrapace, Bioheart, CardioMEMS.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Guidant:
Typical Co-investors
Guidant is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Guidant:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Ankang Venture Investment -
Balance Ventures California, San Francisco, United States
Club Invest 77 France, Ile-de-France, Serris
Compuware Ventures Detroit, Michigan, United States
Cruttenden Partners California, Newport Beach, United States
dtac Accelerate Bangkok, Krung Thep, Thailand
Geekdom Australia, New South Wales, Sydney
Gojo & Company, Inc. Japan, Tokyo
Gollust Management -
Highlander Partners Dallas, Texas, United States
Jupiter Capital Bangalore, India, Karnataka
Masters Capital Nanotechnology Chicago, Illinois, United States
Mentha Capital Amsterdam, Noord-Holland, The Netherlands
New Directions Cleveland, Ohio, United States
RAD Data Communications Israel, Tel Aviv, Tel Aviv District
Redbud Capital -
Southwest Michigan First Kalamazoo, Michigan, United States
Tanium Kirkland, United States, Washington
WISENEXT Lisboa, Lisbon, Portugal

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Remon Medical Technologies

Health Care
Medical
Medical Device
$10M10 Jan 2005 North District

Intrapace

Biotechnology
Health Care
Health Diagnostics
$14M14 Jul 2004 San Jose, California, United States

Evalve

Health Care
Manufacturing
Medical Device
$35M25 May 2004 California, United States

CardioMEMS

Health Care
Medical
Pharmaceutical
$14M26 Nov 2003 Atlanta, Georgia, United States

CardioNet

Biotechnology
Health Care
Medical Device
$13M13 Jan 2003 Pennsylvania, United States

CardioFocus

Biotechnology
Health Care
Medical Device
Pharmaceutical
Surgical Devices
Therapeutic Devices
$1M02 Aug 2001 Marlborough, Massachusetts, United States

CardioFocus

Biotechnology
Health Care
Medical Device
Pharmaceutical
Surgical Devices
Therapeutic Devices
$9M06 Jan 2000 Marlborough, Massachusetts, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Guidant?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 10
Average round size 13M
Rounds per year 0.37
Peak activity year 2004
Lead investments 1
Follow on index 0.20
Exits 5
Group Appearance index 0.90

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Remon Medical Technologies

Health Care
Medical
Medical Device
$10M10 Jan 2005 North District

Intrapace

Biotechnology
Health Care
Health Diagnostics
$14M14 Jul 2004 San Jose, California, United States

Evalve

Health Care
Manufacturing
Medical Device
$35M25 May 2004 California, United States

CardioMEMS

Health Care
Medical
Pharmaceutical
$14M26 Nov 2003 Atlanta, Georgia, United States

CardioNet

Biotechnology
Health Care
Medical Device
$13M13 Jan 2003 Pennsylvania, United States

CardioFocus

Biotechnology
Health Care
Medical Device
Pharmaceutical
Surgical Devices
Therapeutic Devices
$1M02 Aug 2001 Marlborough, Massachusetts, United States

CardioFocus

Biotechnology
Health Care
Medical Device
Pharmaceutical
Surgical Devices
Therapeutic Devices
$9M06 Jan 2000 Marlborough, Massachusetts, United States
Crunchbase icon

Content report

The following text will be sent to our editors: